article thumbnail

Cloud robotics labs are accelerating drug discovery and development

Pharmaceutical Technology

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development.

article thumbnail

Top 10 Most Environmentally Sustainable Pharma Companies in 2023/2024

XTalks

There was also significant variability in emissions, up to five times, between pharma companies with comparable revenues. For example, Proctor & Gamble was found to emit almost five times more CO 2 e than Johnson & Johnson despite the two companies having similar revenue levels and producing similar lines of products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices.

article thumbnail

AI as Business Leverage in Pharma & Life Sciences

pharmaphorum

If there was an AI solution in the Life Sciences field, able to represent a real opportunity in terms of Customer Engagement and Digital Transformation, and if some of the most important players in the industry already had it, would you like to have the opportunity to listen to them? . . ” . .

article thumbnail

4 Life Sciences Trends for 2023

XTalks

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

article thumbnail

Launching a life sciences company: How to stand out from the crowd

Drug Discovery World

DDW’s Diana Spencer speaks to the CEOs of two drug discovery start-ups to find out how they have overcome the challenges of launching a new company in a competitive market. It’s a challenging time to launch a new company in the life sciences sector. billion was raised by biopharma companies in 2022, down by 48.6%

article thumbnail

The benefits of being a family-run pharma company

pharmaphorum

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.